MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1245/s10434-026-19347-0

Медицинская библиотека · Annals of surgical oncology · 2026

Fewer Pills, Lower Bills: Antihypertensive and Cost Outcomes of Adrenalectomy in Primary Aldosteronism.

Passman Jesse E, Owei Lily, Brensinger Colleen, Barrett Taryn, Kelz Lauren R, Hwang Jasmine, Cohen Jordana B, Wachtel Heather

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Primary aldosteronism (PA) can be treated surgically or medically depending on disease lateralization and surgical candidacy. There is a dearth of data directly comparing antihypertensive medication trajectories and costs between these strategies.

PATIENTS AND

METHODS

We performed a retrospective cohort study of patients with new PA diagnoses and adrenal vein sampling to assess antihypertensive medication outcomes and treatment costs using Optum's de-identified Clinformatics® Data Mart Database (2004-2022). Patients were stratified by receipt of adrenalectomy versus medical management alone. The index time point was defined as adrenal vein sampling (AVS) for medically managed and adrenalectomy for surgically managed patients. Outcomes were assessed using regression models.

RESULTS

Of 911 patients, 52% underwent adrenalectomy and 48% medical therapy. Adrenalectomy patients were younger, with higher Elixhauser scores. Antihypertensive medication use (2.9 versus 2.8, p = 0.636) and costs did not differ at index. After 1 year, adrenalectomy patients used fewer antihypertensive medications (1.5 ± 1.4) than medically managed patients (2.5±1.5, p < 0.001). On regression, age (β = 0.02, p = 0.002), male sex (β = 0.40, p < 0.001), and baseline antihypertensive medications (β = 0.43, p < 0.001) were associated with higher antihypertensive medication requirement. Adrenalectomy patients were prescribed 1.11 fewer antihypertensive medications at one year (p < 0.001). In the resistant hypertension subcohort, adrenalectomy reduced antihypertensive medications by 1.35 (p < 0.001). Adrenalectomy was associated with US $908 lower antihypertensive medication prescription costs (p < 0.001) and 87% lower odds of potassium supplementation (p < 0.001).

CONCLUSIONS

Patients with PA who undergo adrenalectomy demonstrate a significant reduction in antihypertensive medications compared with medically managed patients. While there is significant upfront cost to surgical intervention, reduced long-term prescription costs are realized.

Для цитирования: Passman Jesse E, Owei Lily, Brensinger Colleen, Barrett Taryn, Kelz Lauren R, Hwang Jasmine, Cohen Jordana B, Wachtel Heather. Fewer Pills, Lower Bills: Antihypertensive and Cost Outcomes of Adrenalectomy in Primary Aldosteronism.. Annals of surgical oncology. 2026. DOI: 10.1245/s10434-026-19347-0.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.